ArticleMolecular biology reports2025
Primary ovarian insufficiency due to homozygous variants in the homeobox transcription factor NOBOX.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposePrimary ovarian insufficiency (POI) is characterized by the loss of normal ovarian function and depletion of the ovarian reserve before the age of 40. Approximately 4-30% of reported POI cases are familial, indicating a genetic cause. The Newborn Ovary Homeobox (NOBOX) gene, an oocyte-specific transcription factor, plays an essential role in ovarian development and oogenesis in vertebrates. Pathogenic variants in the NOBOX gene are reported to cause autosomal dominant premature ovarian failure (OMIM 610934).
methodsWhole-exome sequencing (WES) was performed in a consanguineous family with two sisters affected by non-syndromic POI, and a familial history of ovarian anomalies and infertility. All exons of both sisters were sequenced by WES, and the segregation was confirmed by Sanger sequencing.
resultsHere, we identified a pathogenic homozygous missense variant (c.1048G > T, p.V350L) in the homeobox domain of NOBOX in the two sisters. The mother a confirmed carrier of the variant, currently aged 43, had her last child at the age of 40 and continues to have regular menstruation cycles.
conclusionThis data, together with other recent studies, indicates that POI due to variants in the NOBOX gene may be an autosomal recessive form of female infertility rather than an autosomal dominant condition. These findings support the reclassification of NOBOX-related POI as an autosomal recessive disorder and highlight the need for systematic genetic screening of NOBOX in patients with POI and their families.
Indexed as
Identifiers
41324758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.